Lui Franciosi To Assess the Safety and Efficacy of a New Dementia Treatment VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be reviewing and monitoring the safety and efficacy of the new...

Lui Franciosi Sends His Season Greetings and Best Wishes for 2022 VANCOUVER, British Columbia , Dec. 28, 2021 (GLOBE NEWSWIRE) -- Lui Franciosi would like to send his season greetings and best wishes for a successful 2022 to all clients and friends. It has been...

Franciosi Consulting Assessing New Potential Treatments for Asthma and COPD VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be assessing the use of glycosaminoglycans (GAGs) for the...

Lui Franciosi Reviewing the Use of Sugar-Based Molecules as Potential Treatments for COVID-19 VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be reviewing the pharmacological feasibility of using specific...

Luigi Franciosi to Advise on New Asthma & COPD Drug Development Programs for Vicenna Pharmaceuticals Inc. VANCOUVER, British Columbia, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Franciosi Consulting Ltd. (“FCL”) is pleased to announce that its President and CEO, Dr. Luigi Franciosi, has been retained as a...